Vendor, Cary, NC, part of Valline SRL
Chiesi USA Inc.
UEI M3FAV5PM8B15, CAGE 483E9
3 awards and $0 obligated between February 16, 2024 and September 2, 2026, 100% under full and open competition, against 333.7 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79721A0020April 15, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Incorporate the Product Additions of 4 Juxtapid NDCS and 1 Myalept NDC to BPA 36E79721A0020.NAICS 325412, PSC 6505 | $0 |
| 36E79726A0025September 2, 2026, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Myalept and JuxtapidNAICS 325412, PSC 6505 | $0 |
| 36F79720D0214February 16, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Product AdditionsNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 30 across 3 awards